Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients? [electronic resource]
Producer: 20100506Description: 403-408 p. digitalISSN:- 1569-8041
- Antineoplastic Agents -- administration & dosage
- Benzamides
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Disease Progression
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Gastrointestinal Stromal Tumors -- drug therapy
- Humans
- Imatinib Mesylate
- Male
- Medical Futility
- Middle Aged
- Neoplasm Metastasis
- Piperazines -- administration & dosage
- Pyrimidines -- administration & dosage
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.